Iloprost Colonis Pharma

Iloprost, the active ingredient in Iloprost Colonis Pharma, is a prostacyclin analog presented as an intravenous solution for use in patients with severe pulmonary arterial hypertension and digital ischemia. It works by selectively activating prostacyclin (IP) receptors to produce vasodilation and inhibit platelet aggregation.

GNH USA supplies Iloprost Colonis Pharma as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals worldwide. The company adheres to EU quality standards and provides reliable logistics for clinical use.

Iloprost is used in the management of vascular disorders that involve pulmonary arterial pressure elevation and peripheral ischemia.

- Pulmonary arterial hypertension: reduces pulmonary vascular resistance and improves exercise capacity. - Digital ischemia: promotes vasodilation to relieve ischemic pain and tissue injury. - Severe Raynaud's phenomenon: alleviates vasospasm and improves digital blood flow.

Common Side Effects: - Headache: mild to moderate, often transient. - Flushing: warm sensation, usually resolves with continued therapy. - Nausea or vomiting: gastrointestinal discomfort during infusion. - Hypotension: drop in blood pressure, monitored during administration. - Jaw pain or toothache: reported during infusion. - Cough or throat irritation: related to intravenous delivery.

Serious or Rare Side Effects: - Severe hypotension: may require medical intervention. - Pulmonary edema: fluid accumulation in lungs, rare but serious. - Significant bleeding: especially when combined with anticoagulants. - Thrombocytopenia: low platelet count, increasing bleeding risk. - Myocardial ischemia: chest pain indicating reduced heart blood flow. - Life‑threatening arrhythmias: abnormal heart rhythms requiring urgent care.

Before initiating therapy, clinicians should consider several safety measures. - Dose titration: start with a low infusion rate and adjust based on tolerance. - Hemodynamic monitoring: continuously monitor blood pressure and heart rate during infusion. - Bleeding risk: avoid in patients with active bleeding or uncontrolled anticoagulation. - Renal impairment: adjust infusion parameters in severe renal dysfunction. - Pregnancy and lactation: use only if potential benefits outweigh potential risks. - Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake.

Iloprost may interact with other medications; careful review is essential.

Major Interactions (Avoid): - Concomitant nitrates or other potent vasodilators: may cause severe hypotension. - Anticoagulants or antiplatelet agents: increased risk of bleeding. - Other prostacyclin analogs (e.g., epoprostenol): additive vasodilatory effect.

Moderate Interactions (Monitor Closely): - Calcium channel blockers: may enhance hypotensive response. - Beta‑blockers: may mask tachycardia, requiring closer monitoring. - Diuretics: may exacerbate hypotension, especially during rapid infusion.